New York State Common Retirement Fund Cogent Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 20,902 shares of COGT stock, worth $186,027. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,902
Previous 29,902
30.1%
Holding current value
$186,027
Previous $252,000
10.32%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding COGT
# of Institutions
170Shares Held
113MCall Options Held
56.7KPut Options Held
40.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$93.2 Million0.31% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.24MShares$82.2 Million8.19% of portfolio
-
Commodore Capital LP New York, NY7.54MShares$67.1 Million6.92% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$64.9 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$62 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $585M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...